THE WHAT Unilever and The Estee Lauder Companies have joined Zero100 – a new community-based education and research platform that aims to ‘connect, inform and inspire a new generation of leaders inventing Zero Percent Carbon, 100% Digital supply chains.’
THE DETAILS According to a press release, through Zero100, Chief Operations and Supply Chain Officers and their teams access a collection of livestream and asynchronous content.
Learning programs and community connections, underpinned by data-driven research, have been created to engage employees and accelerate progress on critical digital and ESG initiatives.
The platform is backed by personal investment from Dave Clark, CEO Worldwide Consumer at Amazon, as well as other carefully selected investors, Zero100.
THE WHY Founding members of Zero100 have a shared purpose to ‘re-imagine the production, distribution and consumption of physical goods around the world and a shared responsibility to collectively redefine how supply chain professionals will shape that future.’
Roberto Canevari, Executive Vice President, Global Supply Chain, The Estée Lauder Companies, says, “We have tremendous opportunity to positively impact our planet, people and communities if we collectively channel our energy towards the intersection of supply chain, digitization and sustainability.
“As a values-driven organization, with a complex global Supply Chain formed by talented and passionate people, The Estée Lauder Companies is proud to be a founding member of Zero100 and we wholeheartedly believe in the Zero Carbon, 100% Digital rallying cry.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
